Epigenotyping in Peripheral Blood Cell DNA and Breast Cancer Risk: A Proof of Principle Study
2008

DNA Methylation in Blood Cells and Breast Cancer Risk

Sample size: 1083 publication 10 minutes Evidence: moderate

Author Information

Author(s): Widschwendter Martin, Apostolidou Sophia, Raum Elke, Rothenbacher Dietrich, Fiegl Heidi, Menon Usha, Stegmaier Christa, Jacobs Ian J., Brenner Hermann

Primary Institution: UCL Institute for Women's Health, University College London

Hypothesis

Can DNA methylation in peripheral blood cell DNA predict breast cancer risk?

Conclusion

The study shows that DNA methylation patterns in blood cells can indicate a woman's risk of developing breast cancer.

Supporting Evidence

  • DNA methylation in blood cells can predict breast cancer risk.
  • Specific genes showed different methylation patterns between breast cancer patients and healthy controls.
  • Lack of methylation in certain genes was associated with increased breast cancer risk.
  • Environmental factors may influence DNA methylation patterns.
  • Breast cancer risk prediction improved when combining traditional risk factors with DNA methylation data.

Takeaway

Scientists found that looking at DNA from blood can help tell if someone might get breast cancer in the future.

Methodology

The study used quantitative methylation analysis in a case-control design with 1,083 participants.

Potential Biases

Potential bias due to the study design and the timing of sample collection.

Limitations

The study samples were obtained after breast cancer diagnosis, which may influence the results.

Participant Demographics

The study included 353 breast cancer cases and 730 age-matched controls, primarily postmenopausal women.

Statistical Information

P-Value

0.006

Confidence Interval

1.12–1.97

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0002656

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication